Core Viewpoint - Dillard's (DDS) is anticipated to report a year-over-year decline in earnings due to lower revenues, with the consensus outlook indicating a potential impact on its near-term stock price [1][3]. Earnings Expectations - The upcoming earnings report is expected to show quarterly earnings of $6.43 per share, reflecting a year-over-year decrease of 16.8% [3]. - Revenues are projected to be $1.42 billion, which is a slight decline of 0.2% compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.42% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Dillard's is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +2.70%, suggesting a recent bullish sentiment among analysts [12]. Historical Performance - Dillard's has consistently beaten consensus EPS estimates, achieving this in the last four quarters [14]. - In the last reported quarter, Dillard's exceeded expectations by delivering earnings of $4.66 per share against an expected $3.79, resulting in a surprise of +22.96% [13]. Predictive Indicators - A positive Earnings ESP is a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank; however, Dillard's currently holds a Zacks Rank of 4, complicating predictions of an earnings beat [10][12]. - The predictive power of the Earnings ESP model is significant primarily for positive readings, indicating that a negative reading does not necessarily predict an earnings miss [9][11]. Conclusion - While Dillard's does not appear to be a compelling candidate for an earnings beat, investors should consider other factors influencing stock performance ahead of the earnings release [17].

Core Viewpoint - The market anticipates Envoy Medical, Inc. (COCH) to report a year-over-year increase in earnings despite flat revenues for the quarter ending September 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus EPS estimate for Envoy Medical is a loss of $0.27 per share, reflecting a year-over-year change of +27% [3]. - Revenues are projected to remain unchanged at $0.06 million compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 9.09% higher in the last 30 days, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +11.11%, suggesting a bullish outlook on earnings [12]. Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10]. - Envoy Medical holds a Zacks Rank of 2, enhancing the likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Envoy Medical was expected to post a loss of $0.29 per share but actually reported a loss of -$0.32, resulting in a surprise of -10.34% [13]. - Over the past four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Context - In the Zacks Medical - Instruments industry, 908 Devices Inc. is expected to report a loss of $0.13 per share for the same quarter, indicating a year-over-year change of +43.5% [18]. - 908 Devices' revenue is projected to decline by 19% to $13.58 million, with a consensus EPS estimate revised 6.3% lower, resulting in an Earnings ESP of -18.42% [19][20].

Core Insights - Sunrise Realty Trust, Inc. (SUNS) is anticipated to report a year-over-year increase in earnings driven by higher revenues for the quarter ended September 2025 [1] - The earnings report is scheduled for release on November 13, and better-than-expected results could lead to a stock price increase, while disappointing results may cause a decline [2] - The consensus estimate for quarterly earnings is $0.31 per share, reflecting a 24% year-over-year increase, with revenues projected at $6.2 million, a 95% increase from the previous year [3] Estimate Revisions Trend - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have not significantly reassessed their initial estimates during this period [4] Earnings Surprise Prediction - The Zacks Earnings ESP model compares the Most Accurate Estimate to the Zacks Consensus Estimate, suggesting that recent estimate revisions may provide more accurate insights into expected earnings [6][7] - A positive Earnings ESP reading is a strong indicator of an earnings beat, especially when combined with a solid Zacks Rank, which enhances predictive power [9]

Core Insights - Wall Street anticipates a year-over-year decline in earnings for Intuitive Machines, Inc. despite higher revenues in the upcoming earnings report for the quarter ended September 2025 [1] - The stock price may react positively if the actual results exceed expectations, while a miss could lead to a decline [2] Financial Expectations - The consensus estimate indicates a quarterly loss of $0.04 per share, reflecting a significant year-over-year change of -300% [3] - Expected revenues are projected at $62.41 million, representing a 6.7% increase from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 18.68% higher in the last 30 days, indicating a reassessment by analysts [4] - It is important to note that aggregate changes may not represent the direction of revisions by individual analysts [4] Earnings Prediction Model - The Zacks Earnings ESP model compares the Most Accurate Estimate to the Zacks Consensus Estimate, providing insights into potential earnings surprises [7][8] - A positive Earnings ESP reading suggests a likely deviation from the consensus estimate, particularly indicating a potential earnings beat [9] Predictive Power of Earnings ESP - A positive Earnings ESP is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10] - Research indicates that stocks with this combination achieve a positive surprise nearly 70% of the time, enhancing the predictive power of Earnings ESP [10]

Core Insights - Suncor Energy Inc. reported third-quarter 2025 adjusted operating earnings of $1.07 per share, exceeding the Zacks Consensus Estimate of 85 cents, driven by strong production growth in its upstream segment, although it slightly declined from $1.08 in the previous year due to lower upstream price realizations [1][9] Financial Performance - Operating revenues reached $9.2 billion, surpassing the Zacks Consensus Estimate by 11.1%, primarily due to increased sales volumes in both upstream and downstream segments, despite a year-over-year decrease of approximately 3.9% [2] - The company declared a quarterly dividend of 60 Canadian cents per share, representing a 5% increase from the previous quarter, payable on December 24, 2025 [2] - Total expenses increased by 0.8% to C$10.5 billion, with operating, selling, and general expenses rising to C$3.3 billion due to higher production and sales volumes, as well as increased share-based compensation [15] Production and Operational Highlights - Suncor achieved record upstream production of 870,000 barrels per day (bbls/d), a 5% increase year-over-year, and exceeded the consensus estimate of 850,000 bbls/d [4][5] - Oil sands bitumen production increased to 958,300 bbls/d from 909,600 bbls/d in the previous year, driven by record output at Fort Hills and Firebag [5] - Refining throughput reached a record of 492,000 bbls/d with refinery utilization at 106%, and refined product sales totaled 647,000 bbls/d, up from 612,300 bbls/d in the prior year [4][12] Cash Flow and Shareholder Returns - The company distributed a total of C$1.4 billion to shareholders, including C$750 million in share repurchases and C$700 million in dividends, while generating C$3.8 billion in adjusted funds from operations and C$2.3 billion in free cash flow [3] - Cash flow from operating activities amounted to C$3.8 billion, down from C$4.3 billion in the prior year, with capital expenditures of C$1.4 billion [16] Guidance and Future Outlook - Suncor raised its 2025 production and throughput guidance, increasing upstream production volumes to a range of 845,000-855,000 bbls/d and refinery throughput to 470,000-475,000 bbls/d [17]

Core Insights - Bio-Techne Corporation (TECH) reported first-quarter fiscal 2026 adjusted earnings per share (EPS) of 42 cents, matching the Zacks Consensus Estimate, with the bottom line remaining flat year-over-year [1][9] - The company's net sales for the quarter were $286.6 million, down 1% year-over-year, missing the Zacks Consensus Estimate by 0.9%, leading to a 7.5% drop in shares during pre-market trading [3][9] Financial Performance - GAAP loss per share was 24 cents compared to EPS of 21 cents in the prior-year quarter [2] - Gross profit increased by 2.8% to $188.1 million, with gross margin expanding by 242 basis points to 65.6% due to a 7.5% decrease in the cost of sales [6][9] - Operating profit for the quarter was $47.7 million, up from $40 million in the year-ago quarter, with an operating margin expansion of 282 basis points to 16.6% [7][9] - Net cash provided by operating activities was $27.6 million, down from $63.9 million a year ago [10] Revenue Breakdown - In the Protein Sciences segment, revenues were $202.2 million, down 1% year-over-year (down 3% organically) [4] - The Diagnostics and Spatial Biology segment saw sales decrease by 4% year-over-year to $79.5 million, although it was up 3% organically [5] Market Position and Outlook - Despite the revenue decline, there are signs of stabilization in the U.S. academic market and continued strength among large pharmaceutical customers [11] - The expansion of both gross and operating margins is viewed as a positive indicator for the company's future performance [12]

Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for HudBay Minerals due to lower revenues, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - HudBay Minerals is expected to report quarterly earnings of $0.08 per share, reflecting a year-over-year decrease of 38.5% [3]. - Revenues are projected to be $440.07 million, down 9.4% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised 45.67% higher in the last 30 days, indicating a reassessment by analysts [4]. - Despite the positive revision trend, the aggregate change may not represent the direction of individual analyst revisions [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for HudBay Minerals is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -21.77% [12]. - The stock currently holds a Zacks Rank of 3, complicating predictions of an earnings beat [12]. Historical Performance - In the last reported quarter, HudBay Minerals exceeded expectations by posting earnings of $0.19 per share against an expected $0.11, resulting in a surprise of +72.73% [13]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [14]. Conclusion - HudBay Minerals does not appear to be a strong candidate for an earnings beat based on current estimates and rankings, but other factors should also be considered for investment decisions [17].

Core Insights - Sleep Number reported a revenue of $342.88 million for the quarter ended September 2025, reflecting a year-over-year decline of 19.6% [1] - The company's EPS for the same period was $0.07, compared to -$0.14 a year ago, indicating a recovery in earnings despite the revenue drop [1] - The reported revenue fell short of the Zacks Consensus Estimate of $365.85 million, resulting in a surprise of -6.28% [1] - The EPS also missed the consensus estimate of $0.15, with a surprise of -53.33% [1] Financial Performance Metrics - Sleep Number's stock has returned -13% over the past month, contrasting with the Zacks S&P 500 composite's +1% change, indicating underperformance [3] - The company currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance against the broader market in the near term [3] - The number of stores at the end of the period was 611, which is below the average estimate of 630 by two analysts [4] - Total company sales change rates were reported at -20%, compared to an estimated -13% by two analysts [4] - The number of stores at the beginning of the period was 630, matching the average estimate of 630 by two analysts [4]

Core Insights - Paramount Skydance (PSKY) is projected to report quarterly earnings of $0.49 per share, unchanged from the previous year, with revenues expected to reach $6.79 billion, reflecting a year-over-year increase of 0.8% [1] Revenue Estimates - Analysts estimate 'Revenues- TV Media' to be $3.94 billion, indicating a year-over-year decline of 8.4% [4] - 'Revenues- Filmed Entertainment' is projected at $647.98 million, showing a year-over-year increase of 9.8% [4] - 'Revenues- Direct-to-Consumer' is expected to be $2.11 billion, representing a year-over-year growth of 13.6% [4] Detailed Revenue Breakdown - 'Revenues- Direct-to-Consumer- Advertising' is forecasted to reach $501.94 million, reflecting a year-over-year decrease of 1% [5] - 'Revenues- Filmed Entertainment- Licensing and Other' is estimated at $494.00 million, indicating a year-over-year increase of 2.9% [5] - 'Revenues- TV Media- Advertising' is projected to be $1.42 billion, showing a year-over-year decline of 15.1% [5] Additional Revenue Insights - 'Revenues- TV Media- Affiliate and subscription' is expected to reach $1.72 billion, indicating a year-over-year decline of 7.9% [6] - 'Revenues- TV Media- Licensing and other' is projected at $778.22 million, reflecting a year-over-year increase of 2.4% [6] - 'Revenues- Affiliate and subscription fees' is estimated to be $3.37 billion, showing a year-over-year growth of 4.8% [6] Subscription and Theatrical Revenue - 'Revenues- Direct-to-Consumer- Subscription' is expected to reach $1.64 billion, indicating a year-over-year increase of 22.5% [7] - 'Revenues- Filmed Entertainment- Theatrical' is projected at $136.63 million, reflecting a year-over-year growth of 26.5% [7] Overall Performance - The estimated 'Revenues- Advertising' is projected to be $1.93 billion, indicating a year-over-year decline of 11.5% [8] - Paramount Skydance shares have decreased by 19.8% over the past month, contrasting with the Zacks S&P 500 composite's increase of 1% [8]

The upcoming report from M/A-Com (MTSI) is expected to reveal quarterly earnings of $0.93 per share, indicating an increase of 27.4% compared to the year-ago period. Analysts forecast revenues of $260.13 million, representing an increase of 29.6% year over year.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnin ...